Patent details

91073 Product Name: EMTRICITABINE et ses dérivés pharmaceutiquement acceptables (EMTRIVA)

Basic Information

Publication number:
91073
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP919044545
Legal Status:
Expired
Application number:
91073
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/03/261/001-003
Marketing Authorization Type:
Marketing Authorization Date:
24/10/2003
Marketing Authorization Status:
Accepted
Marketing Authorization Country:

Dates

Filing date:
23/04/2004
First Marketing Authorization date:
24/10/2003
Grant date:
24/06/2004
Activation date:
31/01/2011
Publication date:
24/06/2004
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
31/01/2016
SPC Extension Expiration:
31/01/2016
Rejection date:
Withdrawal date:

Owner

From:
23/04/2004
 
 

Name:
EMORY UNIVERSITY
Address:
1364 Clifton Road, N.E., Box M, Atlanta, GA 30322, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
23/04/2004
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
CHOI Woo-Baeg
Address:
United States (US)

2

Name:
SCHINAZI Raymond F
Address:
United States (US)

3

Name:
LIOTTA Dennis, C.
Address:
United States (US)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
27/01/2015
Last Annual Fee Paid Number:
25
Last Annual Fee Paid Amount:
450 Euro
Payer:
OFFICE FREYLINGER S.A.
Filing date Document type Number of pages